CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy

NCT02654977 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Familial Partial Lipodystrophy
Nonalcoholic Steatohepatitis
NAFLD

Interventions

DRUG: Metreleptin

Sponsor

University of Michigan